설명
In vivo tumor growth data from xenograft models comparing melatonin-treated and control groups. Tumor volume measurements suggest MLT suppresses prostate cancer growth.
Figure 18
ChartSource Paper
Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.Cite This Figure
![Figure 18: In vivo tumor growth data from xenograft models comparing melatonin-treated and control groups. Tumor volume measurements suggest MLT suppresses prostate cancer growth.]() > Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)
<figure> <img src="" alt="In vivo tumor growth data from xenograft models comparing melatonin-treated and control groups. Tumor volume measurements suggest MLT suppresses prostate cancer growth." /> <figcaption>Figure 18. In vivo tumor growth data from xenograft models comparing melatonin-treated and control groups. Tumor volume measurements suggest MLT suppresses prostate cancer growth.<br> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption> </figure>